Reduced Global Efficiency and Random Network Features in Patients with Relapsing-Remitting Multiple Sclerosis with Cognitive Impairment

被引:13
|
作者
Hawkins, R. [1 ]
Shatil, A. S. [1 ]
Lee, L. [2 ]
Sengupta, A. [1 ]
Zhang, L. [1 ]
Morrow, S. [3 ]
Aviv, R., I [4 ,5 ,6 ]
机构
[1] Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Toronto, ON, Canada
[2] Sunnybrook Hlth Sci Ctr, Dept Med, Div Neurol, Toronto, ON, Canada
[3] Univ Hosp, London Hlth Sci Ctr, Lawson Hlth Res Inst, Div Neurol, London, ON, Canada
[4] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada
[5] Univ Ottawa, Dept Radiol, CPCR Bldg,Room L2121, Ottawa, ON K1H 1M2, Canada
[6] Ottawa Hosp, Div Neuroradiol, Ottawa, ON, Canada
关键词
STRUCTURAL CORTICAL NETWORKS; WHITE; DECLINE; PERFORMANCE; ATTENTION; PATHOLOGY; DISEASE; SPEED;
D O I
10.3174/ajnr.A6435
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: Graph theory uses structural similarity to analyze cortical structural connectivity. We used a voxel-based definition of cortical covariance networks to quantify and assess the relationship of network characteristics to cognition in a cohort of patients with relapsing-remitting MS with and without cognitive impairment. MATERIALS AND METHODS: We compared subject-specific structural gray matter network properties of 18 healthy controls, 25 patients with MS with cognitive impairment, and 55 patients with MS without cognitive impairment. Network parameters were compared, and predictive value for cognition was assessed, adjusting for confounders (sex, education, gray matter volume, network size and degree, and T1 and T2 lesion load). Backward stepwise multivariable regression quantified predictive factors for 5 neurocognitive domain test scores. RESULTS: Greater path length (r = ?0.28, P < .0057) and lower normalized path length (r = 0.36, P < .0004) demonstrated a correlation with average cognition when comparing healthy controls with patients with MS. Similarly, MS with cognitive impairment demonstrated a correlation between lower normalized path length (r = 0.40, P < .001) and reduced average cognition. Increased normalized path length was associated with better performance for processing (P < .001), learning (P < .001), and executive domain function (P = .0235), while reduced path length was associated with better executive (P = .0031) and visual domains. Normalized path length improved prediction for processing (R-2 = 43.6%, G(2) = 20.9; P < .0001) and learning (R-2 = 40.4%, G(2) = 26.1; P < .0001) over a null model comprising confounders. Similarly, higher normalized path length improved prediction of average z scores (G(2) = 21.3; P < .0001) and, combined with WM volume, explained 52% of average cognition variance. CONCLUSIONS: Patients with MS and cognitive impairment demonstrate more random network features and reduced global efficiency, impacting multiple cognitive domains. A model of normalized path length with normal-appearing white matter volume improved average cognitive z score prediction, explaining 52% of variance.
引用
收藏
页码:449 / 455
页数:7
相关论文
共 50 条
  • [41] Prodrome in relapsing-remitting and primary progressive multiple sclerosis
    Wijnands, J. M. A.
    Zhu, F.
    Kingwell, E.
    Zhao, Y.
    Evans, C.
    Fisk, J. D.
    Marrie, R. A.
    Tremlett, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (07) : 1032 - 1036
  • [42] Social Cognition Impairments in Relapsing-Remitting Multiple Sclerosis
    Henry, Audrey
    Tourbah, Ayman
    Chaunu, Marie-Pierre
    Rumbach, Lucien
    Montreuil, Michele
    Bakchine, Serge
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2011, 17 (06) : 1122 - 1131
  • [43] Specificity of attention and cognitive inhibition processes in relapsing-remitting multiple sclerosis patients with consideration of their mood level
    Tyburski, Ernest
    Potemkowski, Andrzej
    Chec, Magdalena
    Soltys, Anna
    Mak, Monika
    Samochowiec, Agnieszka
    PSYCHIATRIA POLSKA, 2014, 48 (02) : 307 - 318
  • [44] Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis
    Debernard, Laetitia
    Melzer, Tracy R.
    Alla, Sridhar
    Eagle, Jane
    Van Stockum, Saskia
    Graham, Charlotte
    Osborne, Jonathan R.
    Dalrymple-Alford, John C.
    Miller, David H.
    Mason, Deborah F.
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2015, 234 (03) : 352 - 361
  • [45] Cognitive trajectories in relapsing-remitting multiple sclerosis: A longitudinal 6-year study
    Damasceno, Alfredo
    Pimentel-Silva, Luciana Ramalho
    Damasceno, Benito Pereira
    Cendes, Fernando
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (13) : 1740 - 1751
  • [46] Prevalence and prognostic value of prodromal symptoms in relapsing-remitting multiple sclerosis
    Kania, Karolina
    Ambrosius, Wojciech
    Dyczkowska, Klara
    Kozubski, Wojciech
    Kalinowska-Lyszczarz, Alicja
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2023, 57 (03) : 289 - 296
  • [47] Radiomics Nomograms Based on Multi-sequence MRI for Identifying Cognitive Impairment and Predicting Cognitive Progression in Relapsing-Remitting Multiple Sclerosis
    Wang, Xiaohua
    Liu, Shangqing
    Yan, Zichun
    Yin, Feiyue
    Feng, Jinzhou
    Liu, Hao
    Liu, Yanbing
    Li, Yongmei
    ACADEMIC RADIOLOGY, 2025, 32 (01) : 411 - 424
  • [48] Longitudinal analysis of verbal episodic memory in patients with relapsing-remitting multiple sclerosis
    Fonte Boa, Izadora Nogueira
    Rimkus, Carolina de Medeiros
    Companholo, Kenia Repiso
    Apostolos Pereira, Samira Luisa
    Junqueira, Thiago de Faria
    Rodrigues Machado, Melissa de Almeida
    Callegaro, Dagoberto
    Garcia Otacluy, Maria Concepcion
    Leite, Claudia da Costa
    Miotto, Eliane Correa
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2018, 76 (05) : 302 - 309
  • [49] Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing-Remitting Multiple Sclerosis
    Escribano, Begona M.
    Aguilar-Luque, Macarena
    Bahamonde, Carmen
    Conde, Cristina
    Lillo, Rafael
    Sanchez-Lopez, Fernando
    Giraldo, Ana I.
    Cruz, Antonio H.
    Luque, Evelio
    Gascon, Felix
    Aguera, Eduardo
    Tunez, Isaac
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (31) : 4876 - 4880
  • [50] Human herpes virus 6 status in relapsing-remitting multiple sclerosis patients
    Nejati, Ahmad
    Shoja, Zabihollah
    Farahmand, Mohammad
    Shahmahmoodi, Shohreh
    Akrami, Kaveh
    Hamid, Kabir M.
    Tafakhori, Abbas
    Doosti, Rozita
    Sahraian, Mohammad A.
    Marashi, Sayed M.
    INTERNAL MEDICINE JOURNAL, 2017, 47 (03) : 339 - 341